Number of Manufacturers and Generic Drug Pricing From 2005 to 2017
Regardless of the number of manufacturers, generic drug prices presented double-digit average increases from 2012 to 2015.
Trends in Opioid and Nonsteroidal Anti-Inflammatory Use and Adverse Events
Opioid use incidence and prevalence rates decreased with implementation of an opioid safety initiative, whereas nonsteroidal anti-inflammatory drug rates remained constant. Rates of adverse events were higher among opioid users.
Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011
From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.
FDA Warning and Removal of Rosiglitazone From VA National Formulary
After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.
Variation in Prescription Use and Spending for Lipid-Lowering and Diabetes Medications in the Veterans Affairs Healthcare System
Substantial variation in prescription spending and use of brand-name drugs exists across the VA healthcare system, with no apparent relationship to quality of care.
VA Pharmacy Users: How They Differ From Other Veterans
A higher proportion of veterans who use VA pharmacy services are black, have no alternative insurance, have lower incomes, are disabled, and report poorer health.
Pharmacy Benefits Management in the Veterans Health Administration: 1995 to 2003
Physician Satisfaction with Formulary Policies: Is it Access to Formulary or Nonformulary Drugs that Matters Most?
Lansoprazole Overutilization: Methods for Step-Down Therapy
Physician Perceptions of a National Formulary
Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization
2 Commerce Drive Cranbury, NJ 08512